Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 24, 2022

Treatment Adaptations and Outcomes for IBD Flares During the Early COVID-19 Pandemic

Alimentary Pharmacology & Therapeutics


Additional Info

Alimentary Pharmacology & Therapeutics
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study
Aliment. Pharmacol. Ther. 2022 Nov 01;56(10)1460-1474, A Saifuddin, AJ Kent, SJ Mehta, LC Hicks, HA Gonzalez, JP Segal, MJ Brookes, S Subramanian, N Bhala, TE Conley, KV Patel, , CA Lamb, GJ Walker, NA Kennedy, S Sebastian

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading